AstraZeneca vaccine shows 79% efficacy in trials but is not without controversy; Everlywell acquires PWNHealth and subsidiary Home Access Health . Plus: U.S. Department of Veterans Affairs undertaking a strategic review of its Cerner electronic health record modernization program .

Links to the stories:

AstraZeneca vaccine shows 79% efficacy in phase III trial

AstraZeneca is questioned over potential use of outdated information in its COVID-19 clinical trial

Everlywell forms new at-home lab testing subsidiary through PWNHealth purchase

VA to undertake strategic review of EHR modernization program